Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease

Biomarkers in Medicine

Volumn 7, Issue 5, 2013, Pages 737-745

  Boyraz, Mehmet ^a   Cekmez, Ferhat ^b   Karaoglu, Abdulbaki ^b   Cinaz, Peyami ^c   Durak, Mustafa ^d   Bideci, Aysun ^c  

^a Sisli Etfal Education Hospital   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

^d MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

adiponectin; leptin; metabolic syndrome; NAFLD; obese children; RBP 4; resistin

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN; RESISTIN; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHEMICAL ANALYSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; ENZYME ACTIVITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPOKINES; ADIPONECTIN; ADOLESCENT; CHILD; FATTY LIVER; HUMANS; LEPTIN; METABOLIC SYNDROME X; OBESITY; RESISTIN; RETINOL-BINDING PROTEINS, PLASMA; ROC CURVE;

EID: 84884547035     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.13.13     Document Type: Article

References (48)

1. Takahashi N, Qi Y, Patel HR, Ahima RS. A novel aminosterol reverses diabetes and fatty liver disease in obese mice. J. Hepatol. 41(3), 391-398 (2004
2. Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr. Opin. Lipidol. 16(4), 421-427 (2005
3. Adams LA, Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabet. Med. J. Br. Diabet. Assoc. 22(9), 1129-1133 (2005
4. Cortez-Pinto H, Camilo ME. Non-alcoholic fatty liver disease/non- alcoholic steatohepatitis (NAFLD/NASH): Diagnosis and clinical course. Best Pract. Res. Clin. Gastroenterol. 18(6), 1089-1104 (2004
5. Marion AW, Baker AJ, Dhawan A. Fatty liver disease in children. Arch. Dis. Child. 89(7), 648-652 (2004
6. Rahimi RS, Landaverde C. Nonalcoholic fatty liver disease and the metabolic syndrome: Clinical implications and treatment. Nutr. Clin. Pract. 28(1), 40-51 (2013
7. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89(6), 2548-2556 (2004
8. Higashiura K, Ura N, Ohata J et al. Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations. Clin. Endocrinol. 61(6), 753-759 (2004
9. Asayama K, Hayashibe H, Dobashi K et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes. Res. 11(9), 1072-1079 (2003
10. Chrzanowska J, Zubkiewicz-Kucharska A, Noczynska A. Adipocytokines concentration and metabolic parameters in obese children. Pediatr. Endocrinol. Diabetes Metab. 17(3), 145-151 (2011
11. Puberty and its disorders. In: Pediatric Endocrinology (5th Edition). Lifshitz F (Ed.). Informa Healthcare, NY, USA (2007
12. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2Suppl. 4th Report), S555-S576 (2004
13. National Cholesterol Education Program (NCEP): Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 89(3), 495-501 (1992
14. Tershakovec AM, DJ Rader. Disorders of lipoprotein metabolism and transport. In: Nelson Textbook of Pediatrics (17th Edition). Behrman RE, Kilegman RM, Jenson HB (Eds). Elsevier Health Sciences, PA, USA, 448 (2004
15. Rosenbloom AL. Diabetes diagnosis in the child and adolescent: Diagnosis and classification. In: Pediatric Endocrinology (5th Edition). Lifshitz F (Ed.). Informa Healthcare, NY, USA, 58 (2007
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412-419 (1985
17. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115(4), e500-e503 (2005
18. WHO. Diabetes Mellitus: Report of a WHO Study Group. WHO, Switzerland, 9-17 (1985
19. Singh GK. Metabolic syndrome in children and adolescents. Curr. Treat. Options Cardiovasc. Med. 8(5), 403-413 (2006
20. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 107(4), 1103-1109 (1994
21. Needleman L, Kurtz AB, Rifkin MD, Cooper HS, Pasto ME, Goldberg BB. Sonography of diffuse benign liver disease: Accuracy of pattern recognition and grading. AJR Am. J. Roentgenol. 146, 1011-1015 (1986
22. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br. Med. J. (Clin. Res. Ed.). 292, 13-15 (1986
23. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ 172(7), 899-905 (2005
24. Louthan MV, Barve S, McClain CJ, Joshi-Barve S. Decreased serum adiponectin: An early event in pediatric nonalcoholic fatty liver disease. J. Pediatr. 47(6), 835-838 (2005
25. Iorio R, Sepe A, Giannattasio A et al. Immune phenotype and serum leptin in children with obesity-related liver disease. J. Clin. Endocrinol. Metab. 91(1), 341-344 (2006
26. Zou CC, Liang L, Hong F, Fu JF, Zhao ZY. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocr. J. 52(5), 519-524 (2005
27. Lebensztejn DM, Wojtkowska M, Skiba E, Werpachowska I, Tobolczyk J, Kaczmarski M. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. Adv. Med. Sci. 54(2), 177-182 (2009
28. Burgert TS, Taksali SE, Dziura J et al. Alanine aminotransferase levels and fatty liver in childhood obesity: Associations with insulin resistance, adiponectin, and visceral fat. J. Clin. Endocrinol. Metab. 91(11), 4287-4294 (2006
29. Mandato C, Lucariello S, Licenziati MR, Franzese A, Spagnuolo MI, Ficeralla R et al. Metabolic, hormonal, oxidative, and inflamatory factors in pediatric obesity-related liver disease. J. Pediatr. 147(1), 62-66 (2005
30. Seo JA, Kim NH, Park SY et al. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin. Endocrinol. 68(4), 555-560 (2008
31. Wu H, Jia W, Bao Y et al. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with Type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 79(2), 185-190 (2008
32. Romanowska A, Lebensztejn DM, Skiba E, Tarasow E, Kaczmarski M. Retinol binding protein-4 as a serum biomarker of intrahepatic lipid content in obese children-preliminary report. Acta Biochim. Pol. 58(1), 35-38 (2011
33. Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: A critical appraisal of current data and implications for future research. J. Pediatr. Gastroenterol. Nutr. 43(4), 413-427 (2006
34. Baranova A, Gowder SJ, Schlauch K et al. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance. Obes. Surg. 16(9), 1118-1125 (2006
35. Venturi C, Zoppini G, Zamboni C, Muggeo M. Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose tolerance. Nutr. Metab. Cardiovasc. Dis. 14(4), 200-204 (2004
36. Aller R, de Luis DA, Fernandez L et al. Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease. Dig. Dis. Sci. 53(4), 1088-1092 (2008
37. Perseghin G, Lattuada G, De Cobelli F et al. Serum resistin and hepatic fat content in nondiabetic individuals. J. Clin. Endocrinol. Metab. 91(12), 5122-5125 (2006
38. Yagmur E, Weiskirchen R, Gressner AM, Trautwein C, Tacke F. Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. Diabetes Care 30(5), 1168-1172 (2007
39. Nobili V, Alkhouri N, Alisi A et al. Retinol-binding protein 4: A promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 7(5), 575-579 (2009
40. Milner KL, van der Poorten D, Xu A et al. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology 49(6), 1926-1934 (2009
41. Schina M, Koskinas J, Tiniakos D et al. Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease. Hepatol. Res. 39(10), 972-978 (2009
42. Alkhouri N, Lopez R, Berk M, Feldstein AE. Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 43(10), 985-989 (2009
43. Graham TE, Wason CJ, Bluher M, Kahn BB. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia 50(4), 814-823 (2007
44. Zheng M, Cai WM, Weng HL, Liu RH. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis. World J. Gastroenterol. 8(6), 1073-1076 (2002
45. Patel K, Gordon SC, Jacobson I et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J. Hepatol. 41(6), 935-942 (2004
46. Manco M, Marcellini M, Giannone G, Nobili V. Correlation of serum TNF-a levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am. J. Clin. Pathol. 127(6), 954-960 (2007
47. Kim HC, Choi SH, Shin HW et al. Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women. World J. Gastroenterol. 11(34), 5314-5321 (2005
48. Sundaram SS, Zeitler P, Nadeau K. The metabolic syndrome and nonalcoholic fatty liver disease in children. Curr. Opin. Pediatr. 21(4), 529-535 (2009